IgA Nephropathy
Diagnosis and management of Berger's disease.
Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Clinical Guidelines
Chronic kidney disease: assessment and management (NICE guideline NG203)
National
Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care (Royal College of Physicians, 2008)National
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular DiseasesNational
KDIGO 2024 Clinical Practice Guideline for the Management of IgA NephropathyNational
NICE guideline [TA937]: Targeted-release budesonide for treating primary IgA nephropathyNational
Evidence-Based Clinical Practice Guidelines for IgA Nephropathy 2014Local
IPNA Clinical Practice Recommendations for the Diagnosis and Management of Children with IgA Nephropathy and IgA Vasculitis with NephritisLocal
IPNA Clinical Practice Recommendations for the Diagnosis and Management of Children with IgA Nephropathy and IgA Vasculitis with NephritisLocal
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular DiseasesLocal
KDIGO 2024 Clinical Practice Guideline for the Management of IgA Nephropathy and IgA Vasculitis (Public Review Draft)Local
KDIGO 2025 Clinical Practice Guideline for the Management of IgA Nephropathy and IgA VasculitisLocal
KDIGO 2025 Clinical Practice Guideline for the Management of IgA Nephropathy and IgA VasculitisLocal